MBA is a leading independent player in orthopedic and emergency surgery with operations in Spain, Portugal, and Italy. The company offers solutions, high-quality products, and adds customer value through high clinical expertise and service to both public and private customers in Spain, Portugal, and Italy. The group operates in ten therapeutic segments where orthopedic implants for reconstruction of, among others, hips, knees, and shoulders, as well as products and solutions mainly for spine and neurosurgery, trauma, and anesthesia are the main areas. The corporate culture at MBA is characterized by an entrepreneurial spirit, high service level, and great customer focus.

The operations from Telia Health Monitoring have been integrated into the subsidiary Camanio and renamed to Camanio Health. Camanio Health is a digital platform solution that enables self-monitoring for patients with chronic diseases such as heart failure, high blood pressure, COPD, diabetes, and IBD.

BioCat markets and sells a broad portfolio of instruments and reagents in the rapidly growing areas of genomics, proteomics, and cell biology to research-oriented customers in universities and colleges, pharmaceutical companies, and biotechs. The company distributes products and services from around 70 suppliers.
The acquisition strengthens AddLife's presence in Germany while also opening up opportunities for collaboration with our other companies in Europe that operate in the same product segment.